ID   BRE1A_HUMAN             Reviewed;         975 AA.
AC   Q5VTR2; A7MCT5; Q2TB34; Q69YL5; Q6P527; Q8N3J4; Q96JD3; Q9H9Y7;
AC   Q9HA51; Q9NUR4; Q9NWQ3; Q9NX83;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 2.
DT   10-MAY-2017, entry version 142.
DE   RecName: Full=E3 ubiquitin-protein ligase BRE1A;
DE            Short=BRE1-A;
DE            Short=hBRE1;
DE            EC=2.3.2.27 {ECO:0000269|PubMed:16307923, ECO:0000269|PubMed:16337599, ECO:0000269|PubMed:19410543};
DE   AltName: Full=RING finger protein 20;
DE   AltName: Full=RING-type E3 ubiquitin transferase BRE1A {ECO:0000305};
GN   Name=RNF20; Synonyms=BRE1A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RA   Wu H., Xie Y., Ying K., Mao Y.M.;
RT   "A novel RING finger protein RNF20 gene specially expressed in
RT   testis.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ileal mucosa, Mammary gland, Placenta, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thyroid;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 453-975.
RC   TISSUE=Amygdala, and Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, AND IDENTIFICATION IN A COMPLEX
RP   WITH RNF40 AND UBE2E1.
RX   PubMed=16307923; DOI=10.1016/j.molcel.2005.09.025;
RA   Zhu B., Zheng Y., Pham A.-D., Mandal S.S., Erdjument-Bromage H.,
RA   Tempst P., Reinberg D.;
RT   "Monoubiquitination of human histone H2B: the factors involved and
RT   their roles in HOX gene regulation.";
RL   Mol. Cell 20:601-611(2005).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND INTERACTION
RP   WITH TP53.
RX   PubMed=16337599; DOI=10.1016/j.molcel.2005.11.012;
RA   Kim J., Hake S.B., Roeder R.G.;
RT   "The human homolog of yeast BRE1 functions as a transcriptional
RT   coactivator through direct activator interactions.";
RL   Mol. Cell 20:759-770(2005).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-522, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBUNIT.
RX   PubMed=19410543; DOI=10.1016/j.cell.2009.02.027;
RA   Kim J., Guermah M., McGinty R.K., Lee J.S., Tang Z., Milne T.A.,
RA   Shilatifard A., Muir T.W., Roeder R.G.;
RT   "RAD6-mediated transcription-coupled H2B ubiquitylation directly
RT   stimulates H3K4 methylation in human cells.";
RL   Cell 137:459-471(2009).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH PA2G4, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=19037095; DOI=10.1091/mbc.E08-09-0983;
RA   Liu Z., Oh S.M., Okada M., Liu X., Cheng D., Peng J., Brat D.J.,
RA   Sun S.Y., Zhou W., Gu W., Ye K.;
RT   "Human BRE1 is an E3 ubiquitin ligase for Ebp1 tumor suppressor.";
RL   Mol. Biol. Cell 20:757-768(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-136 AND SER-138, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-348, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-138, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   INTERACTION WITH WAC.
RX   PubMed=21329877; DOI=10.1016/j.molcel.2011.01.024;
RA   Zhang F., Yu X.;
RT   "WAC, a functional partner of RNF20/40, regulates histone H2B
RT   ubiquitination and gene transcription.";
RL   Mol. Cell 41:384-397(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-138, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-41; SER-136 AND SER-138,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-136 AND SER-138, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Component of the RNF20/40 E3 ubiquitin-protein ligase
CC       complex that mediates monoubiquitination of 'Lys-120' of histone
CC       H2B (H2BK120ub1). H2BK120ub1 gives a specific tag for epigenetic
CC       transcriptional activation and is also prerequisite for histone H3
CC       'Lys-4' and 'Lys-79' methylation (H3K4me and H3K79me,
CC       respectively). It thereby plays a central role inb histone code
CC       and gene regulation. The RNF20/40 complex forms a H2B ubiquitin
CC       ligase complex in cooperation with the E2 enzyme UBE2A or UBE2B;
CC       reports about the cooperation with UBE2E1/UBCH are contradictory.
CC       Required for transcriptional activation of Hox genes. Recruited to
CC       the MDM2 promoter, probably by being recruited by p53/TP53, and
CC       thereby acts as a transcriptional coactivator. Mediates the
CC       polyubiquitination of isoform 2 of PA2G4 in cancer cells leading
CC       to its proteasome-mediated degradation.
CC       {ECO:0000269|PubMed:16307923, ECO:0000269|PubMed:16337599,
CC       ECO:0000269|PubMed:19037095, ECO:0000269|PubMed:19410543}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000269|PubMed:16307923,
CC       ECO:0000269|PubMed:16337599, ECO:0000269|PubMed:19410543}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Component of the RNF20/40 complex (also known as BRE1
CC       complex) probably composed of 2 copies of RNF20/BRE1A and 2 copies
CC       of RNF40/BRE1B. Interacts with UBE2E1/UBCH6. Interacts with
CC       p53/TP53 and WAC. Interacts with PAF1; the interaction mediates
CC       the association of the PAF1 and RNF20/40 complexes which is a
CC       prerequsite for recruitment of UBE2A/B. Interacts with isoform 1
CC       and isoform 2 of PA2G4. {ECO:0000269|PubMed:16307923,
CC       ECO:0000269|PubMed:16337599, ECO:0000269|PubMed:19037095,
CC       ECO:0000269|PubMed:19410543, ECO:0000269|PubMed:21329877}.
CC   -!- INTERACTION:
CC       Q9Y2J4-4:AMOTL2; NbExp=3; IntAct=EBI-2372238, EBI-10187270;
CC       O96017:CHEK2; NbExp=3; IntAct=EBI-2372238, EBI-1180783;
CC       Q92905:COPS5; NbExp=2; IntAct=EBI-2372238, EBI-594661;
CC       P42858:HTT; NbExp=3; IntAct=EBI-2372238, EBI-466029;
CC       O75150:RNF40; NbExp=10; IntAct=EBI-2372238, EBI-744408;
CC       P51965:UBE2E1; NbExp=2; IntAct=EBI-2372238, EBI-348546;
CC       Q8N6Y0:USHBP1; NbExp=3; IntAct=EBI-2372238, EBI-739895;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19037095,
CC       ECO:0000305|PubMed:16337599}.
CC   -!- TISSUE SPECIFICITY: Expressed in the normal brain and also in
CC       malignant gliomas (at protein level).
CC       {ECO:0000269|PubMed:19037095}.
CC   -!- SIMILARITY: Belongs to the BRE1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH63115.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=BAA91326.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAA92057.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAB14005.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF265230; AAK58539.1; -; mRNA.
DR   EMBL; AK000389; BAA91134.1; ALT_SEQ; mRNA.
DR   EMBL; AK000697; BAA91326.1; ALT_INIT; mRNA.
DR   EMBL; AK002051; BAA92057.1; ALT_INIT; mRNA.
DR   EMBL; AK022300; BAB14005.1; ALT_INIT; mRNA.
DR   EMBL; AK022532; BAB14081.1; -; mRNA.
DR   EMBL; AK314401; BAG37025.1; -; mRNA.
DR   EMBL; AL591377; CAH69963.1; -; Genomic_DNA.
DR   EMBL; AL353621; CAH69963.1; JOINED; Genomic_DNA.
DR   EMBL; AL353621; CAI14618.1; -; Genomic_DNA.
DR   EMBL; AL591377; CAI14618.1; JOINED; Genomic_DNA.
DR   EMBL; BC063115; AAH63115.1; ALT_SEQ; mRNA.
DR   EMBL; BC110584; AAI10585.1; -; mRNA.
DR   EMBL; BC110585; AAI10586.1; -; mRNA.
DR   EMBL; BC152309; AAI52310.1; -; mRNA.
DR   EMBL; AL832910; CAH10630.1; -; mRNA.
DR   EMBL; AL834272; CAD38947.1; -; mRNA.
DR   CCDS; CCDS35084.1; -.
DR   RefSeq; NP_062538.5; NM_019592.6.
DR   RefSeq; XP_011517164.1; XM_011518862.1.
DR   UniGene; Hs.729085; -.
DR   PDB; 5TRB; X-ray; 1.80 A; A=906-975.
DR   PDBsum; 5TRB; -.
DR   ProteinModelPortal; Q5VTR2; -.
DR   SMR; Q5VTR2; -.
DR   BioGrid; 121119; 81.
DR   DIP; DIP-53411N; -.
DR   IntAct; Q5VTR2; 41.
DR   MINT; MINT-3054538; -.
DR   STRING; 9606.ENSP00000373772; -.
DR   iPTMnet; Q5VTR2; -.
DR   PhosphoSitePlus; Q5VTR2; -.
DR   DMDM; 84027766; -.
DR   EPD; Q5VTR2; -.
DR   MaxQB; Q5VTR2; -.
DR   PaxDb; Q5VTR2; -.
DR   PeptideAtlas; Q5VTR2; -.
DR   PRIDE; Q5VTR2; -.
DR   Ensembl; ENST00000389120; ENSP00000373772; ENSG00000155827.
DR   GeneID; 56254; -.
DR   KEGG; hsa:56254; -.
DR   UCSC; uc004bbn.5; human.
DR   CTD; 56254; -.
DR   DisGeNET; 56254; -.
DR   GeneCards; RNF20; -.
DR   HGNC; HGNC:10062; RNF20.
DR   HPA; CAB012478; -.
DR   HPA; HPA051773; -.
DR   MIM; 607699; gene.
DR   neXtProt; NX_Q5VTR2; -.
DR   OpenTargets; ENSG00000155827; -.
DR   PharmGKB; PA34427; -.
DR   eggNOG; KOG0978; Eukaryota.
DR   eggNOG; ENOG410Y5C6; LUCA.
DR   GeneTree; ENSGT00390000002866; -.
DR   HOVERGEN; HBG080312; -.
DR   InParanoid; Q5VTR2; -.
DR   KO; K10696; -.
DR   OMA; NKELAGN; -.
DR   OrthoDB; EOG091G01SA; -.
DR   PhylomeDB; Q5VTR2; -.
DR   TreeFam; TF323183; -.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   SIGNOR; Q5VTR2; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; RNF20; human.
DR   GeneWiki; RNF20; -.
DR   GenomeRNAi; 56254; -.
DR   PRO; PR:Q5VTR2; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000155827; -.
DR   ExpressionAtlas; Q5VTR2; baseline and differential.
DR   Genevisible; Q5VTR2; HS.
DR   GO; GO:0033503; C:HULC complex; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000151; C:ubiquitin ligase complex; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0042393; F:histone binding; IDA:UniProtKB.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB.
DR   GO; GO:0002039; F:p53 binding; IDA:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0033523; P:histone H2B ubiquitination; IDA:UniProtKB.
DR   GO; GO:0010390; P:histone monoubiquitination; IDA:UniProtKB.
DR   GO; GO:0030336; P:negative regulation of cell migration; IDA:UniProtKB.
DR   GO; GO:1900364; P:negative regulation of mRNA polyadenylation; IMP:UniProtKB.
DR   GO; GO:2001168; P:positive regulation of histone H2B ubiquitination; IMP:UniProtKB.
DR   GO; GO:0031062; P:positive regulation of histone methylation; IEA:Ensembl.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; IDA:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; TAS:Reactome.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IMP:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   Gene3D; 3.90.1150.10; -; 1.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_sub2.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   SMART; SM00184; RING; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chromatin regulator; Coiled coil;
KW   Complete proteome; Metal-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Transferase; Ubl conjugation pathway; Zinc;
KW   Zinc-finger.
FT   CHAIN         1    975       E3 ubiquitin-protein ligase BRE1A.
FT                                /FTId=PRO_0000055836.
FT   ZN_FING     922    961       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   COILED       43     90       {ECO:0000255}.
FT   COILED      168    375       {ECO:0000255}.
FT   COILED      429    898       {ECO:0000255}.
FT   MOD_RES      21     21       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q3U319}.
FT   MOD_RES      41     41       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     136    136       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     138    138       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     348    348       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     510    510       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q3U319}.
FT   MOD_RES     522    522       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     562    562       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q3U319}.
FT   CONFLICT    149    149       G -> GKW (in Ref. 3; CAH69963/CAI14618).
FT                                {ECO:0000305}.
FT   CONFLICT    285    285       E -> Q (in Ref. 2; BAA91134/BAA91326).
FT                                {ECO:0000305}.
FT   CONFLICT    289    289       N -> D (in Ref. 1; AAK58539).
FT                                {ECO:0000305}.
FT   CONFLICT    322    322       A -> V (in Ref. 2; BAB14081).
FT                                {ECO:0000305}.
FT   CONFLICT    668    668       K -> E (in Ref. 2; BAB14081).
FT                                {ECO:0000305}.
FT   CONFLICT    693    693       K -> T (in Ref. 1; AAK58539).
FT                                {ECO:0000305}.
FT   CONFLICT    699    699       D -> E (in Ref. 2; BAB14081).
FT                                {ECO:0000305}.
FT   HELIX       908    920       {ECO:0000244|PDB:5TRB}.
FT   TURN        923    925       {ECO:0000244|PDB:5TRB}.
FT   STRAND      926    929       {ECO:0000244|PDB:5TRB}.
FT   STRAND      932    934       {ECO:0000244|PDB:5TRB}.
FT   TURN        935    937       {ECO:0000244|PDB:5TRB}.
FT   HELIX       943    951       {ECO:0000244|PDB:5TRB}.
FT   TURN        958    960       {ECO:0000244|PDB:5TRB}.
FT   STRAND      968    971       {ECO:0000244|PDB:5TRB}.
SQ   SEQUENCE   975 AA;  113662 MW;  D75C7BE02880594A CRC64;
     MSGIGNKRAA GEPGTSMPPE KKAAVEDSGT TVETIKLGGV SSTEELDIRT LQTKNRKLAE
     MLDQRQAIED ELREHIEKLE RRQATDDASL LIVNRYWSQF DENIRIILKR YDLEQGLGDL
     LTERKALVVP EPEPDSDSNQ ERKDDRERGE GQEPAFSFLA TLASSSSEEM ESQLQERVES
     SRRAVSQIVT VYDKLQEKVE LLSRKLNSGD NLIVEEAVQE LNSFLAQENM RLQELTDLLQ
     EKHRTMSQEF SKLQSKVETA ESRVSVLESM IDDLQWDIDK IRKREQRLNR HLAEVLERVN
     SKGYKVYGAG SSLYGGTITI NARKFEEMNA ELEENKELAQ NRLCELEKLR QDFEEVTTQN
     EKLKVELRSA VEQVVKETPE YRCMQSQFSV LYNESLQLKA HLDEARTLLH GTRGTHQHQV
     ELIERDEVSL HKKLRTEVIQ LEDTLAQVRK EYEMLRIEFE QTLAANEQAG PINREMRHLI
     SSLQNHNHQL KGEVLRYKRK LREAQSDLNK TRLRSGSALL QSQSSTEDPK DEPAELKPDS
     EDLSSQSSAS KASQEDANEI KSKRDEEERE RERREKERER EREREKEKER EREKQKLKES
     EKERDSAKDK EKGKHDDGRK KEAEIIKQLK IELKKAQESQ KEMKLLLDMY RSAPKEQRDK
     VQLMAAEKKS KAELEDLRQR LKDLEDKEKK ENKKMADEDA LRKIRAVEEQ IEYLQKKLAM
     AKQEEEALLS EMDVTGQAFE DMQEQNIRLM QQLREKDDAN FKLMSERIKS NQIHKLLKEE
     KEELADQVLT LKTQVDAQLQ VVRKLEEKEH LLQSNIGTGE KELGLRTQAL EMNKRKAMEA
     AQLADDLKAQ LELAQKKLHD FQDEIVENSV TKEKDMFNFK RAQEDISRLR RKLETTKKPD
     NVPKCDEILM EEIKDYKARL TCPCCNMRKK DAVLTKCFHV FCFECVKTRY DTRQRKCPKC
     NAAFGANDFH RIYIG
//
